US Closed System Transfer Devices Market worth USD 0.86 billion by 2031
The report "US Closed System Transfer Devices Market by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luer), Technology (Air Cleaning/Filtration Devices), End User (Hospitals Clinics) - Forecast to 2031" is projected to reach USD 0.86 billion by 2031 from USD 0.67 billion in 2026 at a CAGR of 5.0% during the forecast period.
Browse 150 market data Tables and 80 Figures spread through 200 Pages and in-depth TOC on "US Closed System Transfer Devices, by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luer), Technology (Air Cleaning/Filtration Devices), End User (Hospitals Clinics) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-closed-system-transfer-devices-market-89652630.html
Mandatory adherence to USP <800> is a key driver of the U.S. CSTD market, supported by the growing number of injectable oncology and specialty therapies and increasing awareness of occupational exposure risks among healthcare professionals. However, market growth is constrained by the high initial and ongoing costs of consumables, workflow disruptions during implementation, and limited adoption in smaller facilities due to budget limitations. At the same time, the market presents notable opportunities, including the expansion of CSTD use beyond oncology into biologics and gene therapies, rapid growth in ambulatory and home infusion settings, usability-focused design innovations, and the potential for stricter enforcement of safety regulations.
The membrane-to-membrane systems segment will hold the largest share by type in the US closed system transfer devices market.
The membrane-to-membrane CSTD systems hold the largest share in the US market, owing to their ability to provide a very tight, dry-to-dry connection that effectively resists the leakage of hazardous drugs and the escape of vapors. Their strong clinical validation, harmonious compatibility with standard vials and infusion systems, and straightforward alignment with USP <800> and NIOSH recommendations facilitate their easy acceptance in hospitals. Early market entry, a large installed base, and clinician familiarity have also cemented a preference for membrane-to-membrane designs in oncology and specialty pharmacy settings.
Diaphragm-based devices segment held the highest revenue share of the US closed system transfer devices market in 2024
The CSTD devices with diaphragms dominate the US market because they provide highly reliable containment of hazardous drugs through mechanical seals on fluid pathways and pressure equalization. Proven efficacy in preventing vapor and aerosol escape translates into strong compliance with USP <800> and NIOSH guidelines. Signs of established clinical use, extreme confidence among pharmacists and nurses, and widespread use in large hospital systems all serve to strengthen the dominance of diaphragm-based technologies over competing designs.
Key Market Players:
The key players in the US closed system transfer devices market include BD (US), ICU Medical, Inc. (US), EQUASHIELD (US), Corning Incorporated (US), Simplivia Healthcare Ltd. (Israel), JMS (Japan), Baxter (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (Germany), West Pharmaceuticals Services, Inc. (US), CODAN Medizinische Geräte GmbH (Germany), Yukon Medical (US), and INSUNG MEDICAL Co., Ltd. (South Korea).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the US Closed System Transfer Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
